Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Vaccinations01:51

Vaccinations

Overview
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Canadian Adverse Events Following Immunization Surveillance System (CAEFISS): Annual report for vaccines administered in 2012.

Canada communicable disease report = Releve des maladies transmissibles au Canada·2018
Same author

Canada's Vaccine Vigilance Working Group.

Canada communicable disease report = Releve des maladies transmissibles au Canada·2018
Same author

The Canadian Immunization Monitoring Program, ACTive (IMPACT): Active surveillance for vaccine adverse events and vaccine-preventable diseases.

Canada communicable disease report = Releve des maladies transmissibles au Canada·2018
Same author

Epiglottitis in Canada: A multiregional review.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012
Same author

An update on respiratory syncytial virus epidemiology: a developed country perspective.

Respiratory medicine·2002
Same author

Chickenpox vaccination, not chickenpox, should be routine for Canadian children.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2001

Related Experiment Video

Updated: Jun 16, 2026

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

Towards universal childhood immunization against chickenpox?

B J Law1

  • 1Department of Pediatrics and Child Health, University of Manitoba and Winnipeg Hospital, Winnipeg, Manitoba.

Paediatrics & Child Health
|February 24, 2010
PubMed
Summary

Varicella vaccine offers significant protection against chickenpox, reducing severe illness and reactivation. Despite concerns, childhood immunization is crucial for population health, as children account for most hospitalizations and fatalities.

Keywords:
ChickenpoxShinglesVaccineVaricella zoster

More Related Videos

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
09:37

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique

Published on: September 23, 2022

Related Experiment Videos

Last Updated: Jun 16, 2026

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
09:37

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique

Published on: September 23, 2022

Area of Science:

  • Immunology
  • Vaccinology
  • Public Health

Background:

  • Live attenuated varicella vaccine is available in Canada, with recommendations for immunization.
  • Universal childhood immunization is limited to Prince Edward Island.
  • Barriers include perceptions of chickenpox severity, vaccine effectiveness concerns, and waning immunity fears.

Purpose of the Study:

  • To assess the benefits of varicella immunization.
  • To compare the natural history of chickenpox with vaccine effectiveness.
  • To address concerns regarding vaccine efficacy and long-term effects.

Main Methods:

  • Comparative analysis of disease natural history and vaccine effectiveness data.
  • Review of clinical trial data and population-based disease burden statistics.
  • Evaluation of risks associated with natural varicella infection versus vaccination.

Main Results:

  • Chickenpox is often mild but causes significant hospitalizations and fatalities in children.
  • Vaccine effectiveness ranges from 70-86% against any chickenpox and 95-100% against severe illness.
  • Vaccination significantly reduces the frequency and severity of reactivation illness.

Conclusions:

  • Varicella immunization is beneficial for both individual and public health.
  • The vaccine effectively mitigates severe disease and reactivation episodes.
  • Addressing barriers is essential for achieving high childhood vaccine coverage.